This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://dx.doi.org/10.1111/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q85763020
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в серпні 2013 im August 2013 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'agostu de 2013 scientific article published on 28 August 2013 wetenschappelijk artikel
p:P577
wds:Q85763020-C532B12A-DC0F-4958-B8F7-6620D2C10373
wdt:P577
2013-08-28T00:00:00Z
p:P2093
wds:Q85763020-AD67AFB2-FC59-4B34-982F-99EBBCCAD74A wds:Q85763020-913DE434-E88D-42D9-B798-02A8A979A763 wds:Q85763020-FC7BE7B1-9645-4A47-BAFE-91F71AF5524E wds:Q85763020-C600A6DD-298E-4EC3-BEC9-4EC51764F2B0
wdt:P2093
J Marier K Laliberte L Peterson T Marbury
rdfs:label
An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairment An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairment
skos:prefLabel
An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairment An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairment
schema:name
An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairment An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairment
p:P1476
wds:Q85763020-AE99465F-2584-44AB-ABCB-0DE372102B60
wdt:P1476
An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairment
p:P304
wds:Q85763020-66F8A66D-1499-48C7-B614-9DE8920ECDFB
wdt:P304
518-523
p:P31
wds:Q85763020-9C047BF6-0037-443A-90CA-78BFC8D0E12D
wdt:P31
wd:Q13442814
p:P921
wds:Q85763020-DAE3E02A-B1EE-41DE-9A88-98EDF84ABAE3 wds:Q85763020-00A9A905-435F-429C-9BDF-F7EA8EB60FCD
wdt:P921
wd:Q323936 wd:Q3495231
p:P698
wds:Q85763020-943B8E5D-600C-4A59-8207-39C9332E7CB5
wdtn:P698
n12:24033615
wdt:P698
24033615
p:P1433
wds:Q85763020-A4F3E89F-61DC-4EC9-931A-215E42283245
wdt:P1433
wd:Q15753553
p:P433
wds:Q85763020-17D28B02-676C-4CCB-A1CE-F69125DA8C81
p:P478
wds:Q85763020-C63A086B-51F4-43D4-B1F4-7ACA358BFEA1
wdt:P433
6
wdt:P478
38
p:P356
wds:Q85763020-AEB963AD-8178-43B8-9917-C25BFA7E81D1
wdtn:P356
n4:JCPT.12094
wdt:P356
10.1111/JCPT.12094